Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Today we’re previewing NeuralPLexer3 Beta: demonstrating unprecedented accuracy and speed in predicting protein-drug complexes, with instant and accurate structural insights across the full range of protein classes and drug molecules. Learn more:

iambic_ai's profile picture

Iambic Therapeutics

3,390 subscribers

57,456 Aufrufe • vor 1 Jahr •via X (Twitter)

BildungGesundheit & WellnessWissenschaft & Technologie
LIVE

Anya Rossi• Live Now

Private livecam show

1 Kommentare

Profilbild von Vladas Oleinikovas, PhD 🇪🇺
Vladas Oleinikovas, PhD 🇪🇺vor 1 Jahr

Impressive results on PoseBusters v2 dataset, what time cutoff did you use and are you planning to share the predicted structures for evaluation?

Ähnliche Videos

1/ 🚀 Introducing AIDO.StructureDiffusion: A generative model for structural protein design—enabling high-quality, controllable generation of monomers, complexes, and antibodies. 🧵
0:33

1/ 🚀 Introducing AIDO.StructureDiffusion: A generative model for structural protein design—enabling high-quality, controllable generation of monomers, complexes, and antibodies. 🧵

GenBio AI

918,215 Aufrufe • vor 11 Monaten

Introducing LiteFold DeNovo. Generate hundreds of chemically viable ligands against any protein pocket, evaluate them in real time, and refine with our built in molecular editor. The problem: hit generation in drug discovery is slow, fragmented, and outsourced. With LiteFold DeNovo, it becomes interactive and instant. You can also fragment grow base generated molecules, iterate, and soon run molecular dynamics to test stability. Docking and large scale screening are on the way. When we said we’re building the AI first lab for drug discovery, we meant it. Super excited to what's coming next. Codename: Rosalind Try LiteFold DeNovo today. It’s free. Links in the comments.
1:37

Introducing LiteFold DeNovo. Generate hundreds of chemically viable ligands against any protein pocket, evaluate them in real time, and refine with our built in molecular editor. The problem: hit generation in drug discovery is slow, fragmented, and outsourced. With LiteFold DeNovo, it becomes interactive and instant. You can also fragment grow base generated molecules, iterate, and soon run molecular dynamics to test stability. Docking and large scale screening are on the way. When we said we’re building the AI first lab for drug discovery, we meant it. Super excited to what's coming next. Codename: Rosalind Try LiteFold DeNovo today. It’s free. Links in the comments.

Anindya

23,157 Aufrufe • vor 9 Monaten

Many protein complexes that drive key processes in cells are “molecular motors”—assemblies that consume (electro)chemical energy to produce mechanical work. A 2023 #SciencePerspective discusses how insights from biophysical, biochemical, and structural studies are starting to yield an understanding of the mechanism by which these motors extrude loops of DNA to structure genomes. Learn more:
0:52

Many protein complexes that drive key processes in cells are “molecular motors”—assemblies that consume (electro)chemical energy to produce mechanical work. A 2023 #SciencePerspective discusses how insights from biophysical, biochemical, and structural studies are starting to yield an understanding of the mechanism by which these motors extrude loops of DNA to structure genomes. Learn more:

Science Magazine

43,702 Aufrufe • vor 10 Monaten

Engineering Protein Assemblies: Envisioning the future workbench for integrating structural biology and engineering #Science #Engineering #Technology #STEM #STEAM Learn more about the proteins here:
0:24

Engineering Protein Assemblies: Envisioning the future workbench for integrating structural biology and engineering #Science #Engineering #Technology #STEM #STEAM Learn more about the proteins here:

Prash Singh

22,165 Aufrufe • vor 2 Jahren

Learn more about Boltz-2, the new open source AI model from MIT and Recursion capable of predicting protein binding affinity with unprecedented speed, scale and accuracy. ▪️ Boltz-2 is the first model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations while being over 1,000 times faster and less computationally expensive. 💥 The model addresses a critical bottleneck in small molecule drug discovery. ▪️ A powerful tool built on novel machine learning: “By predicting both molecular structure and binding affinity simultaneously with unprecedented speed and scale, Boltz-2 gives R&D teams a powerful tool to triage more effectively and focus resources on the most promising compounds,” says Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. ▪️ The added power of open source: “Because Boltz-2 is open-source, including its training code, scientists can easily adapt it for specific types of molecules, making it even more powerful as a tool to accelerate discovery," says Regina Barzilay, PhD, MIT School of Engineering Distinguished Professor for AI and Health, AI faculty lead at MIT Jameel Clinic for AI & Health and MIT CSAIL principal investigator. 👉 Learn more, read the preprint, and access Boltz-2 here: 📅 Join us for live presentations, demos and discussions: 📎 MIT Presentation (Cambridge) – Monday, June 9. 📎 NVIDIA #GTC25 (Paris) – Wednesday, June 11. 📎 Molecular Machine Learning Conference - MoML (Montreal) – Tuesday, June 17.
1:01

Learn more about Boltz-2, the new open source AI model from MIT and Recursion capable of predicting protein binding affinity with unprecedented speed, scale and accuracy. ▪️ Boltz-2 is the first model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations while being over 1,000 times faster and less computationally expensive. 💥 The model addresses a critical bottleneck in small molecule drug discovery. ▪️ A powerful tool built on novel machine learning: “By predicting both molecular structure and binding affinity simultaneously with unprecedented speed and scale, Boltz-2 gives R&D teams a powerful tool to triage more effectively and focus resources on the most promising compounds,” says Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. ▪️ The added power of open source: “Because Boltz-2 is open-source, including its training code, scientists can easily adapt it for specific types of molecules, making it even more powerful as a tool to accelerate discovery," says Regina Barzilay, PhD, MIT School of Engineering Distinguished Professor for AI and Health, AI faculty lead at MIT Jameel Clinic for AI & Health and MIT CSAIL principal investigator. 👉 Learn more, read the preprint, and access Boltz-2 here: 📅 Join us for live presentations, demos and discussions: 📎 MIT Presentation (Cambridge) – Monday, June 9. 📎 NVIDIA #GTC25 (Paris) – Wednesday, June 11. 📎 Molecular Machine Learning Conference - MoML (Montreal) – Tuesday, June 17.

Recursion

15,593 Aufrufe • vor 1 Jahr

Here's how to predict binding of tens or hundreds of small molecules to protein assemblies using Boltz 2 in ChimeraX. Accuracy depends on how similar the ligands and binding pockets are to existing experimental structures.
2:57

Here's how to predict binding of tens or hundreds of small molecules to protein assemblies using Boltz 2 in ChimeraX. Accuracy depends on how similar the ligands and binding pockets are to existing experimental structures.

ChimeraX (bsky: chimerax.ucsf.edu)

12,887 Aufrufe • vor 10 Monaten

Consumer Reports analyzed 23 protein powders and shakes — a range of dairy, beef and plant-based protein supplements — and found that more than two-thirds of the products contained more lead in a single serving than what experts say is safe to consume. Jonathan LaPook, M.D looks at the report.
1:47

Consumer Reports analyzed 23 protein powders and shakes — a range of dairy, beef and plant-based protein supplements — and found that more than two-thirds of the products contained more lead in a single serving than what experts say is safe to consume. Jonathan LaPook, M.D looks at the report.

CBS Evening News with Tony Dokoupil

17,106 Aufrufe • vor 8 Monaten

Our global, 30 meter Forest Carbon data is here 🌳🚨 The highly accurate and scalable dataset aims to provide unprecedented insights into forest change and carbon stocks - a crucial tool for ensuring accurate carbon accounting. Learn more:
0:25

Our global, 30 meter Forest Carbon data is here 🌳🚨 The highly accurate and scalable dataset aims to provide unprecedented insights into forest change and carbon stocks - a crucial tool for ensuring accurate carbon accounting. Learn more:

Planet

69,586 Aufrufe • vor 2 Jahren

Protein is the foundation of building muscle, staying full, and hitting your health goals, but not all protein sources are created equal! 🤔 In this video, we showcase 9 foods that pack 30 grams of protein—from plant-based options to classic favorites:⁠ ⁠ 🍣 Solid White Tuna: At just 128 calories, it delivers 30g of protein, 0g carbs, and 0.9g fat—a low-calorie, high-protein MVP! ⁠ 🍤 Shrimp: A lean and virtually carb-free option with 127 calories, 30g of protein, 0g carbs, and 0.8g fat. ⁠ 🐔 Chicken Breast: The meal-prep classic provides 154 calories, 30g of protein, 0g carbs, and 3.8g fat. ⁠ 🥚 Large Eggs: A hearty and versatile option, packing 365 calories, 30g of protein, 5g carbs, and 25g fat. ⁠ 🍶 Greek Yogurt: Creamy and fat-free, with 158 calories, 30g of protein, 9.5g carbs, and 0g fat. ⁠ 🧀 Lactose-Free Cottage Cheese: A creamy choice with 220 calories, 30g of protein, 12.9g carbs, and 5.4g fat. ⁠ 🌱 Firm Tofu: A plant-based, nutrient-rich option with 269 calories, 30g of protein, 3.4g carbs, and 15g fat. ⁠ 🌾 Tempeh: Packed with fiber and protein, it has 272 calories, 30g of protein, 18.8g carbs, and 8.5g fat. ⁠ 🥫 Chickpeas: While carb-heavy, they’re oh-so-satisfying with 596 calories, 30g of protein, 96.6g carbs, and 10g fat.⁠ ⁠ Each food fits into different dietary goals and macro needs—so, which one surprises you the most? Let us know your favorite protein source below! 👇 ⁠
0:44

Protein is the foundation of building muscle, staying full, and hitting your health goals, but not all protein sources are created equal! 🤔 In this video, we showcase 9 foods that pack 30 grams of protein—from plant-based options to classic favorites:⁠ ⁠ 🍣 Solid White Tuna: At just 128 calories, it delivers 30g of protein, 0g carbs, and 0.9g fat—a low-calorie, high-protein MVP! ⁠ 🍤 Shrimp: A lean and virtually carb-free option with 127 calories, 30g of protein, 0g carbs, and 0.8g fat. ⁠ 🐔 Chicken Breast: The meal-prep classic provides 154 calories, 30g of protein, 0g carbs, and 3.8g fat. ⁠ 🥚 Large Eggs: A hearty and versatile option, packing 365 calories, 30g of protein, 5g carbs, and 25g fat. ⁠ 🍶 Greek Yogurt: Creamy and fat-free, with 158 calories, 30g of protein, 9.5g carbs, and 0g fat. ⁠ 🧀 Lactose-Free Cottage Cheese: A creamy choice with 220 calories, 30g of protein, 12.9g carbs, and 5.4g fat. ⁠ 🌱 Firm Tofu: A plant-based, nutrient-rich option with 269 calories, 30g of protein, 3.4g carbs, and 15g fat. ⁠ 🌾 Tempeh: Packed with fiber and protein, it has 272 calories, 30g of protein, 18.8g carbs, and 8.5g fat. ⁠ 🥫 Chickpeas: While carb-heavy, they’re oh-so-satisfying with 596 calories, 30g of protein, 96.6g carbs, and 10g fat.⁠ ⁠ Each food fits into different dietary goals and macro needs—so, which one surprises you the most? Let us know your favorite protein source below! 👇 ⁠

Carbon Diet Coach

20,892 Aufrufe • vor 7 Monaten

ReaSyn is helping to revolutionize drug discovery 🔬 Our new generative AI predicts synthetic pathways for molecules using step-by-step reasoning accelerating drug discovery and scientific breakthroughs. Read more and try the code ➡️ #NVIDIAResearch
0:38

ReaSyn is helping to revolutionize drug discovery 🔬 Our new generative AI predicts synthetic pathways for molecules using step-by-step reasoning accelerating drug discovery and scientific breakthroughs. Read more and try the code ➡️ #NVIDIAResearch

NVIDIA AI Developer

25,451 Aufrufe • vor 9 Monaten

It’s heartbreaking to learn through allegations made today, that some leaders in our country are either working with drug lords, part of drug syndicates, or protecting drug criminals. As someone who despises drugs, with everything in me, this is deeply painful. Drugs have ravaged our youth, creating unemployed and unemployable young people across South Africa. To hear that certain leaders might be complicit in these syndicates is infuriating and hurtful to the core. We must take a stand to clean this country and removed all drug dealers and their enablers in all corridors of power. #ANCYLatWork
0:59

It’s heartbreaking to learn through allegations made today, that some leaders in our country are either working with drug lords, part of drug syndicates, or protecting drug criminals. As someone who despises drugs, with everything in me, this is deeply painful. Drugs have ravaged our youth, creating unemployed and unemployable young people across South Africa. To hear that certain leaders might be complicit in these syndicates is infuriating and hurtful to the core. We must take a stand to clean this country and removed all drug dealers and their enablers in all corridors of power. #ANCYLatWork

Thlologelo Collen Malatji

255,249 Aufrufe • vor 11 Monaten

Demis Hassabis: If you know the structure of a protein, the real question becomes—where will your drug bind, and what will it actually do? That’s where the next wave of AI comes in. Not just predicting structures, but modeling interactions, outcomes, and real biological impact. At Isomorphic Labs, this is already happening—with 17 active drug programs and partnerships with giants like Eli Lilly and Novartis. The goal? Scale that to 100. This is a fundamental shift in how medicine gets built. Instead of slow, expensive trial-and-error in wet labs, AI allows researchers to run thousands of hypotheses in silico—hundreds to thousands of times more efficiently. The wet lab becomes validation, not exploration. Drug discovery is turning into a computational problem. Faster cycles, smarter predictions, and potentially massive breakthroughs in human health.
0:59

Demis Hassabis: If you know the structure of a protein, the real question becomes—where will your drug bind, and what will it actually do? That’s where the next wave of AI comes in. Not just predicting structures, but modeling interactions, outcomes, and real biological impact. At Isomorphic Labs, this is already happening—with 17 active drug programs and partnerships with giants like Eli Lilly and Novartis. The goal? Scale that to 100. This is a fundamental shift in how medicine gets built. Instead of slow, expensive trial-and-error in wet labs, AI allows researchers to run thousands of hypotheses in silico—hundreds to thousands of times more efficiently. The wet lab becomes validation, not exploration. Drug discovery is turning into a computational problem. Faster cycles, smarter predictions, and potentially massive breakthroughs in human health.

Ian Miles Cheong

93,680 Aufrufe • vor 2 Monaten

MIT CSAIL, MIT Jameel Clinic for AI & Health, & Recursion have released a protein-binding affinity model called "Boltz-2" that could expand the role of AI in drug discovery. The system predicts how molecules interact — & how tightly they bind — in record time:
1:01

MIT CSAIL, MIT Jameel Clinic for AI & Health, & Recursion have released a protein-binding affinity model called "Boltz-2" that could expand the role of AI in drug discovery. The system predicts how molecules interact — & how tightly they bind — in record time:

MIT CSAIL

18,904 Aufrufe • vor 1 Jahr

In American social networks there are more and more videos with the effects of taking a “zombie drug”
1:02

In American social networks there are more and more videos with the effects of taking a “zombie drug”

S p r i n t e r

72,780 Aufrufe • vor 2 Jahren

.Karoline Leavitt: "President Donald J. Trump has made unprecedented progress toward lowering healthcare costs in this country, and drug prices. He secured numerous Most Favored Nations drug price deals, with many more to come."
0:48

.Karoline Leavitt: "President Donald J. Trump has made unprecedented progress toward lowering healthcare costs in this country, and drug prices. He secured numerous Most Favored Nations drug price deals, with many more to come."

Rapid Response 47

22,732 Aufrufe • vor 6 Monaten

Billionaire and cancer drug pioneer Dr. Patrick Soon-Shiong reveals that the mRNA Spike Protein was engineered to replicate itself, causing havoc within the human body. Watch:
1:13

Billionaire and cancer drug pioneer Dr. Patrick Soon-Shiong reveals that the mRNA Spike Protein was engineered to replicate itself, causing havoc within the human body. Watch:

Kevin Sorbo

138,821 Aufrufe • vor 1 Jahr

How Much Protein Should You Really Eat Daily? | David Allison, Ph.D. This clip is from episode # 368 of The Drive which was released today (10/13/25). In the full episode, we cover: -Why the protein RDA may be inadequate for most people and how to think about optimal intake -What current evidence shows about muscle protein synthesis and high-protein diets -The limitations and biases of nutrition research, including economic and methodological constraints -How processed and ultra-processed foods fit into the broader discussion of obesity and public health -More Watch or listen (Ep. # 368) to the full episode on my website or your favorite podcast player.
0:41

How Much Protein Should You Really Eat Daily? | David Allison, Ph.D. This clip is from episode # 368 of The Drive which was released today (10/13/25). In the full episode, we cover: -Why the protein RDA may be inadequate for most people and how to think about optimal intake -What current evidence shows about muscle protein synthesis and high-protein diets -The limitations and biases of nutrition research, including economic and methodological constraints -How processed and ultra-processed foods fit into the broader discussion of obesity and public health -More Watch or listen (Ep. # 368) to the full episode on my website or your favorite podcast player.

Peter Attia

97,396 Aufrufe • vor 8 Monaten

🚨NEW DRUG TO REGROW TEETH ENTERS HUMAN TRIALS Japanese researchers developed a drug to regrow teeth, set to begin human trials in September. The drug blocks the USAG-1 protein, which suppresses tooth growth. Initial trials will involve adults missing a molar, followed by children with congenital tooth deficiencies and older adults missing teeth due to environmental factors. Successful trials in ferrets and mice showed no serious side effects. The drug could be available by 2030. Sources: Yahoo, cheyssmilejourney on TikTok
2:38

🚨NEW DRUG TO REGROW TEETH ENTERS HUMAN TRIALS Japanese researchers developed a drug to regrow teeth, set to begin human trials in September. The drug blocks the USAG-1 protein, which suppresses tooth growth. Initial trials will involve adults missing a molar, followed by children with congenital tooth deficiencies and older adults missing teeth due to environmental factors. Successful trials in ferrets and mice showed no serious side effects. The drug could be available by 2030. Sources: Yahoo, cheyssmilejourney on TikTok

Mario Nawfal

2,210,496 Aufrufe • vor 2 Jahren

Welcome to Range, the blockchain security and intelligence platform. Today, we're launching the new Range platform, with extended security features, an advanced explorer and much more. Learn more about Range below!
0:44

Welcome to Range, the blockchain security and intelligence platform. Today, we're launching the new Range platform, with extended security features, an advanced explorer and much more. Learn more about Range below!

Range

19,340 Aufrufe • vor 1 Jahr

Boltz-2 was released recently. It is an Open Source protein-ligand co-folding model, which means it can predict the structure of a protein along with the ligand. It has various applications from drug discovery to protein design. I thought why not make a OSS web app for it.
2:00

Boltz-2 was released recently. It is an Open Source protein-ligand co-folding model, which means it can predict the structure of a protein along with the ligand. It has various applications from drug discovery to protein design. I thought why not make a OSS web app for it.

Ravi Sharma

43,890 Aufrufe • vor 1 Jahr